Liver Cancer Trial, Recruiting (NCT05700799)

Liver Cancer Trial, Recruiting NCT05700799 Sponsor: University of California, San Francisco Condition: Liver Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05700799 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Liver Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

The patient must be under 18 years old and have already received a liver transplant.
The patient and/or their parent or legal guardian must be willing and able to sign a consent form agreeing to take part in the study.
The patient and/or their parent or legal guardian must be willing to be contacted by the study team in the future.
The transplant team must feel that the patient and their caregiver are a good fit for this study.

Who may not be able to join:

The caregiver is not willing or is unable to complete a survey as part of the study.
The child is currently in foster care or is a ward of the state.
The patient and/or caregiver speaks a language other than English or Spanish.
The patient does not live in the United States.
The patient is 18 years of age or older at the time they would enroll in the study.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sharad Wadhwani, MD, MPH, University of California, San Francisco

Phone: 510-428-3058

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05700799

Sponsor: University of California, San Francisco

Phase: Not Applicable

Status: Recruiting

Condition: Liver Cancer

Trial contact: 510-428-3058

More information: https://clinicaltrials.gov/study/NCT05700799

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

The patient must be under 18 years old and have already received a liver transplant.
The patient and/or their parent or legal guardian must be willing and able to sign a consent form agreeing to take part in the study.
The patient and/or their parent or legal guardian must be willing to be contacted by the study team in the future.
The transplant team must feel that the patient and their caregiver are a good fit for this study.

Who may not be able to join:

The caregiver is not willing or is unable to complete a survey as part of the study.
The child is currently in foster care or is a ward of the state.
The patient and/or caregiver speaks a language other than English or Spanish.
The patient does not live in the United States.
The patient is 18 years of age or older at the time they would enroll in the study.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, San Francisco

Registry

ClinicalTrials.gov

Start date

20 March 2023

Est. completion

30 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in caregiver experience

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov